Table 1:
Clinical characteristics and pathologic diagnosis of the patients
| Group/Patient No. | Age (yr) | Sex | Histopathologic diagnosis |
|---|---|---|---|
| SBO | |||
| 1 | 66 | M | Chronic inflammation and fibrosis |
| 2 | 41 | F | Active chronic inflammation and fibrosis |
| 3 | 73 | M | Active chronic inflammation and fibrosis |
| 4 | 63 | M | Active chronic inflammation and fibrosis |
| 5 | 56 | M | Chronic inflammation and fibrosis |
| 6 | 56 | M | Chronic inflammation and fibrosis |
| 7 | 81 | M | Chronic inflammation and fibrosis |
| 8 | 57 | F | Chronic inflammation and fibrosis |
| 9 | 61 | M | Chronic inflammation, giant cell reaction, fibrosis |
| NPC | |||
| 1 | 47 | M | SCC, undifferentiated type |
| 2 | 47 | F | SCC, undifferentiated type |
| 3 | 44 | M | SCC, undifferentiated type |
| 4 | 61 | M | SCC, undifferentiated type |
| 5 | 60 | M | SCC, undifferentiated type |
| 6 | 37 | M | SCC, moderately differentiated type |
| 7 | 24 | F | SCC, undifferentiated type |
| 8 | 62 | M | SCC, undifferentiated type |
| 9 | 12 | M | SCC, undifferentiated type |
| Lymphoma | |||
| 1 | 14 | M | B-cell lymphoma |
| 2 | 14 | M | B-cell lymphoma |
| 3 | 14 | M | T-cell lymphoblastic-type lymphoma |
| 4 | 43 | F | Diffuse large B-cell, immunoblastic type lymphoma |
| 5 | 83 | F | Diffuse B-cell lymphoma |
| 6 | 37 | F | Diffuse B-cell lymphoma |
| 7 | 26 | M | T-cell lymphoblastic-type lymphoma |
| 8 | 20 | M | B-cell lymphoma |
| 9 | 49 | M | Diffuse large B-cell lymphoma |
| Metastasis | |||
| 1 | 60 | M | Undifferentiated carcinoma |
| 2 | 53 | M | Undifferentiated carcinoma |
| 3 | 58 | M | Prostate carcinoma |
| 4 | 57 | M | Undifferentiated carcinoma |
| 5 | 50 | M | Moderately differentiated carcinoma |
| 6 | 54 | F | Multiple myeloma |
| 7 | 46 | M | Multiple myeloma |
| 8 | 48 | M | Multiple myeloma |
| 9 | 71 | M | Prostate carcinoma |